Search Results 921-930 of 14788 for anti-TNF drugs

1. Taurolidine And Heparin (Route Not Applicable) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care ...

2. Mayo Clinic researchers review the clinical potential of senolytic drugs on aging

   The drugs being tested are called senolytic agents, because they target senescent cells. ... As senolytic drugs and drug combinations are discovered, researchers ...

3. Betamethasone Dipropionate (Topical Application Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Efavirenz, Emtricitabine, And Tenofovir (Oral Route) Description and Brand Names - Mayo Clinic

   Efavirenz, emtricitabine, and tenofovir combination is used alone or with other anti-HIV medicines to treat human immunodeficiency virus (HIV) infection.

5. Beta-2 Adrenergic Agonist (Oral Route, Injection Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

6. Trastuzumab (Intravenous Route) Description and Brand Names - Mayo Clinic

   It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).

7. Ethinyl Estradiol And Norethindrone (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Femhrt 15; Femhrt Lo; Gildess 1530; Jevantique ...

8. Tazarotene (Topical Route) Precautions - Mayo Clinic

   Precautions. Drug information provided by: Merative, Micromedex®. It is important that your doctor check your progress at regular visits. This will allow ...

9. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas - Mayo Clinic

   Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

10. Computational In Silico Drug Discovery And Design - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

    Dr. Caulfield and his colleagues at Mayo Clinic use structure-based drug design methods to design novel drugs is based on the 3D structures of biological ...